Immunai CTO and Co-Founder Luis Voloch on Using Deep Learning to Develop New Drugs - Ep. 176

0 Anmeldelser
0
Episode
174 of 259
Længde
27M
Sprog
Engelsk
Format
Kategori
Fakta

What if we could map our immune system to create drugs that can help our bodies win the fight against cancer and other diseases? That’s the big idea behind immunotherapy. The problem: the immune system is incredibly complex.

Enter Immunai, a biotechnology company that’s using AI technology to map the human immune system and speed the development of new immunotherapies against cancer and autoimmune diseases.

On this episode of NVIDIA’s AI Podcast, host Noah Kravitz spoke with Luis Voloch, CTO and Co-Founder of Immunai, about tackling the challenges of the immune system with a machine learning and data science mindset.


Lyt når som helst, hvor som helst

Nyd den ubegrænsede adgang til tusindvis af spændende e- og lydbøger - helt gratis

  • Lyt og læs så meget du har lyst til
  • Opdag et kæmpe bibliotek fyldt med fortællinger
  • Eksklusive titler + Mofibo Originals
  • Opsig når som helst
Prøv nu
DK - Details page - Device banner - 894x1036

Other podcasts you might like ...